共 50 条
- [21] Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapyMEDICINE, 2016, 95 (27)Huang, Chung-FengYeh, Ming-LunHuang, Cing-YiTsai, Pei-ChienKo, Yu-MinChen, Kuan-YuLin, Zu-YauChen, Shinn-CherngDai, Chia-YenChuang, Wan-LongHuang, Jee-FuYu, Ming-Lung
- [22] The Presence of Diabetes Reduces Sustained Response after Antiviral Therapy for Post Transplant HCV RecurrenceLIVER TRANSPLANTATION, 2011, 17 (06) : S205 - S205Vero, VittoriaSenzolo, MarcoPasulo, LuisaPonziani, FrancescaVigano, RaffaellaMarino, MariaDonato, MariaRendina, MariaToniutto, PierluigiCescon, MatteoDe Martin, EleonoraMiglioresi, LuciaGiannelli, ValerioDi Paolo, DanieleFagiuoli, Stefano
- [23] Baseline Hematologic Indices in HCV Cirrhosis Patients are Associated with Response to Antiviral Therapy and Clinical DecompensationHEPATOLOGY, 2012, 56 : 1064A - 1065AKaragozian, RaffiGrace, Norman D.Qamar, Amir A.
- [24] Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantationJOURNAL OF HEPATOLOGY, 2007, 46 (03) : 459 - 465Picciotto, Francesco PaoloTritto, GiovanniLanza, Alfonso GaleotaAddario, LuigiDe Luca, MassimoDi Costanzo, GiovanGiuseppeLampasi, FilippoTartaglione, Maria TeresaMarsilia, Giuseppina MarinoCalise, FulvioCuomo, OresteAscione, Antonio
- [25] Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4PLOS ONE, 2016, 11 (04):Rizk, Hanan H.Hamdy, Nadia M.Al-Ansari, Nadia L.El-Mesallamy, Hala O.
- [26] HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1bBMC GASTROENTEROLOGY, 2012, 12Pellicelli, Adriano M.Romano, MarioStroffolini, TommasoMazzoni, EttoreMecenate, FabrizioMonarca, RobertoPicardi, AntonioBonaventura, Maria ElenaMastropietro, CristinaVignally, PascalAndreoli, ArnaldoMarignani, MassimoD'Ambrosio, CeciliaMiglioresi, LuciaNosotti, LorenzoMitidieri, OlgaGentilucci, Umberto VespasianiPuoti, ClaudioBarbaro, GiuseppeBarlattani, AngeloFurlan, CaterinaBarbarini, Giorgio
- [27] HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1bBMC Gastroenterology, 12Adriano M PellicelliMario RomanoTommaso StroffoliniEttore MazzoniFabrizio MecenateRoberto MonarcaAntonio PicardiMaria Elena BonaventuraCristina MastropietroPascal VignallyArnaldo AndreoliMassimo MarignaniCecilia D’AmbrosioLucia MiglioresiLorenzo NosottiOlga MitidieriUmberto Vespasiani GentilucciClaudio PuotiGiuseppe BarbaroAngelo BarlattaniCaterina FurlanGiorgio Barbarini
- [28] HCV genotype 2a shows a better virological response to antiviral therapy than HCV genotype 1bJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 919 - 919Wang, MengLi, Jiansheng
- [29] Liver steatosis reduces the virological response to antiviral therapy in HCV-1/2 but not in HCV-3 infected patientsJOURNAL OF HEPATOLOGY, 2003, 38 : 140 - 141Ferrari, ABoccato, SBenvegnu, LAlberti, A
- [30] HLA CLASS I ALLELES ASSOCIATED WITH HCV POLYMORPHISMS AND RESPONSE TO ANTIVIRAL THERAPY IN HCV GENOTYPE 1-INFECTED PATIENTSJOURNAL OF HEPATOLOGY, 2010, 52 : S270 - S270Lange, C. M.Dragan, A.Roomp, K.Nattermann, J.Michalk, M.Spengler, U.Weich, V.Berg, T.Lengauer, T.Zeuzem, S.Sarrazin, C.
